Fig. 1From: Comparison of 68Ga-PSMA PET/CT and multiparametric MRI for the detection of low- and intermediate-risk prostate cancerStudy flowchart with included and excluded patients as well as the reasons for exclusion. ADT, androgen deprivation therapy. 68Ga-PSMA PET/CT, gallium-68 prostate-specific membrane antigen positron emission tomography/computed tomography; mpMRI, multiparametric magnetic resonance imagingBack to article page